Where next for the Xero (ASX:XRO) share price?

The Xero Limited (ASX:XRO) share price is now down by almost 29% from its 52-week high. Is this a buying opportunity for investors?

| More on:
A woman with black afro hair and wearing a white t-shirt shrugs and purses her lips

Image source: Getty Images

You’re reading a free article with opinions that may differ from The Motley Fool’s Premium Investing Services. Become a Motley Fool member today to get instant access to our top analyst recommendations, in-depth research, investing resources, and more. Learn More

The Xero Limited (ASX: XRO) share price was out of form on Monday and started the week with a small decline.

The cloud-based business and accounting platform provider's shares ended the day 0.5% lower at $112.60.

This latest decline means the Xero share price is now down almost 29% from its 52-week high.

Is the Xero share price in the buy zone?

The market appears reasonably undecided on whether or not the recent weakness in the Xero share price is a buying opportunity.

Following the announcement of its acquisition of Planday last week, analysts at Goldman Sachs retained their buy rating and $157.00 price target.

This price target implies potential upside of almost 40% for its shares over the next 12 months.

The broker believes the acquisition will provide it with a meaningful step into Europe. It also notes that it will help build out its app ecosystem, which is something Goldman is particularly positive on over the long term.

Sitting on the fence

Not everyone is as bullish as Goldman Sachs. One broker that is sitting on the fence is Macquarie. This morning it reaffirmed its neutral rating and trimmed its price target down to $120.00.

While the broker believes the acquisition could contribute around 10% of Xero's total revenue over the long term, it has reduced its near term estimates to reflect its integration.

Macquarie's price target implies potential upside of just 6.6% for the Xero share price over the next 12 months.

Bearish view

Finally, analysts at UBS remain bearish on Xero. While it sees positives in the acquisition, it isn't enough for a change in rating.

UBS continues to believe its shares are overvalued at the current level. In light of this, it has reaffirmed its sell rating with a slightly higher price target of $79.50.

Based on the current Xero share price, this equates to potential downside of almost 30% over the next 12 months.

Time will tell which broker is correct.

Motley Fool contributor James Mickleboro has no position in any of the stocks mentioned. The Motley Fool Australia owns shares of Xero. The Motley Fool has a disclosure policy. This article contains general investment advice only (under AFSL 400691). Authorised by Bruce Jackson.

More on ⏸️ ASX Shares

a woman wearing a close-sitting hat featuring wires and thick computer screen glasses clutches her computer monitor and looks shocked and disturbed as she reads old-fashioned computer text from the screen.
Technology Shares

Here's why ASX 200 tech shares (ASX:XTX) outperformed today

ASX tech shares have taken a turn for the better today.

Read more »

Worker in hard hat looks puzzled with one hand on chin
Resources Shares

Why did the Rio Tinto share price (ASX:RIO) have such a lousy 2021?

We look at what happened to this ASX 200 mining giant's shares last year

Read more »

a miner wearing a hard hat smiles as he stands in front of heavy earth moving equipment on a barren mine site.
Share Gainers

Here's why the Rumble Resources (ASX:RTR) share price is climbing 5%

The mineral explorer's share price is on the rise amid promising drill results.

Read more »

share price high, all time record, record share price, highest, price rise, increase, up,
⏸️ ASX Shares

Here are the top 10 ASX 200 shares on Wednesday

Here are your top 10 biggest gainers in the ASX 200 on Wednesday.

Read more »

comical investor reading documents and surrounded by calculators
⏸️ ASX Shares

The ASX reporting wrap-up: WiseTech, Bravura, Seven Group

Just what the investor ordered. Here’s a recap of the companies that reported on Wednesday...

Read more »

Doctor performing an ultrasound on pregnant woman
⏸️ ASX Shares

The ASX reporting wrap-up: Ansell, Kogan, Nanosonics

Just what the investor ordered. Here’s a recap of the companies that reported on Tuesday...

Read more »

blue arrows representing a rising share price ASX 200
⏸️ ASX Shares

Here are the top 10 ASX 200 shares on Tuesday

Here are your top 10 biggest gainers in the ASX 200 on Tuesday.

Read more »

unhappy investor considering computer screen
Share Market News

The ASX reporting wrap-up: Charter Hall, Ampol, NIB Holdings

Just what the investor ordered. Here’s a recap of the companies that reported on Monday...

Read more »